IL2 and neoplasm: Another relevant factor to be considered in developing an effective immunotherapy for CNS tumor is the strong exhaustion profile induced via continuous TCR/CAR signaling and observed in tumor-infiltrating lymphocytes (TIL) from patients with brain neoplasia, associated to a significant reduction of IL2, IFN-γ and TNFα production (22, 23).